Overview

This trial is active, not recruiting.

Conditions schizophrenia, schizo-affective disorder
Treatment shared decision making training
Sponsor Technische Universität München
Collaborator Isar Amper Klinikum
Start date October 2011
End date December 2014
Trial size 240 participants
Trial identifier NCT02349880, SDM-training

Summary

"Shared decision-making" is being promoted as a promising approach for engaging patients with schizophrenia in medical decisions and improving satisfaction and adherence.

To implement shared decision-making, both physicians and patients should commit to it and engage in a mutual decision process. Most research, however, has addressed interventions that either focus on the doctors' side (e.g. "communication skills") or on informing patients about treatment options (e.g. "decision aids"). These approaches have been shown to be feasible in clinical practice but had no strong effects on treatment patterns or adherence, possibly because they were insufficient to motivate and enable patients to engage actively in decision-making. Moreover, these interventions still rely on the doctor's willingness to share decisions, which has been shown to vary considerably.

To overcome these limitations and since many patients do not feel competent to participate in decision-making we developed an intervention that focuses on patients' communicative competencies. this intervention, a five session group-training, will be implemented for inpatients suffering from schizophrenia.

United States No locations recruiting
Other Countries No locations recruiting

Study Design

Allocation randomized
Endpoint classification efficacy study
Intervention model parallel assignment
Masking open label
Primary purpose health services research
Arm
(Active Comparator)
5 hour cognitive training
shared decision making training
(Experimental)
5 hour shared decision making training
shared decision making training

Primary Outcomes

Measure
adherence to antipsychotic medication
time frame: 12 months

Eligibility Criteria

Male or female participants from 18 years up to 65 years old.

Inclusion Criteria: - age 18-65 - icd diagnosis F2 - sufficient German language skills Exclusion Criteria: - debility

Additional Information

Official title A Shared Decision-making Training for Inpatients With Schizophrenia
Trial information was received from ClinicalTrials.gov and was last updated in January 2015.
Information provided to ClinicalTrials.gov by Technische Universität München.